Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenue $ 52,386,000 $ 43,544,000 $ 150,145,000 $ 124,776,000
Cost of revenue 14,659,000 13,609,000 43,307,000 40,266,000
Gross profit 37,727,000 29,935,000 106,838,000 84,510,000
Operating expenses:        
Sales and marketing 21,159,000 17,801,000 62,678,000 52,474,000
Research and development 9,868,000 8,628,000 29,471,000 24,907,000
General and administrative 13,330,000 11,528,000 38,729,000 33,502,000
Total operating expenses 44,357,000 37,957,000 130,878,000 110,883,000
Loss from operations (6,630,000) (8,022,000) (24,040,000) (26,373,000)
Other income (expense):        
Interest income 520,000 594,000 1,372,000 1,557,000
Interest expense (405,000) (512,000) (1,123,000) (1,485,000)
Other income (expense), net 692,000 874,000 2,278,000 2,457,000
Loss before income taxes (5,823,000) (7,066,000) (21,513,000) (23,844,000)
Provision for income taxes (56,000.0) (79,000.0) (122,100) (148,300)
Net loss $ (5,879,000) $ (7,145,000) $ (21,635,000) $ (23,992,000)
Net loss per share, basic (in dollars per share) $ (0.08) $ (0.10) $ (0.30) $ (0.36)
Net loss per share, diluted (in dollars per share) $ (0.08) $ (0.10) $ (0.30) $ (0.36)
Weighted-average common shares outstanding - basic (in shares) 72,007,727 68,213,250 71,253,586 67,014,127
Weighted-average common shares outstanding - diluted (in shares) 72,007,727 68,213,250 71,253,586 67,014,127